Glycaemic control in type 2 diabetic patients on chronic haemodialysis: use of a continuous glucose monitoring system
Jean‐Pierre Riveline(Inserm), Samy Hadjadj(Université de Poitiers), G. Charpentier(Centre Hospitalier Sud Francilien), J. Teynié(Université de Poitiers), Dured Dardari(Centre Hospitalier Sud Francilien), R. Maréchaud(Centre Hospitalier Universitaire de Poitiers), Sylvia Franc(Centre Hospitalier Sud Francilien), Frank Bridoux(Université de Poitiers), S. Belmouaz(Université de Poitiers), Valérie Caudwell, Stéphanie Ragot(Université de Tours)
Cited by 133
Related Papers
KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases
|Kidney International|2021|2.5k
Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility
|Nature Genetics|2014|1.1k
Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases
|Kidney International|2021|809